Pharmaceutical companies restrained from making diabetes drug https://ift.tt/iD4nH2K

The case involves Germany's Boehringer Ingelheim Pharma GmbH & Co, which claimed a drug named linagliptin used to treat diabetes is patented. It approached the court in 2020, citing a news article that Cadila Healthcare Ltd and West Coast Pharmaceutical Works Ltd had got a tentative licence to export the drug and received permission from the United States Food & Drug Administration (USFDA) for the same.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/BD2Cmoc
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.